Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Nurtec™ ODT (rimegepant) – New drug approval
February 27, 2020 - Biohaven Pharmaceuticals announced the FDA approval of Nurtec ODT (rimegepant), for the acute treatment of migraine with or without aura in adults.
